Abraham M Enyeji (Abraham Enyeji)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Drug Administration

Acute Coronary Syndrome

Antiplatelet Therapy

Acinetobacter Baumannii

Top Venues

International journal of environmental research and public health

Viral immunology

Population health management

This page only lists publications with an associated author ORCID identifier.

Publications

Abraham M Enyeji, Amit Arora, Harpal S Mangat
Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports. Viral immunology (2024)
Abraham M Enyeji, Amit Arora, Harpal S Mangat
Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports. Viral immunology 37 (6) (2024)
Abraham M Enyeji, Amit Arora, Harpal S Mangat
Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports. Viral immunology (2024)
Abraham M Enyeji, Noël Christopher Barengo, Boubakari Ibrahimou, Gilbert Ramirez, Alejandro Arrieta
Association between Non-Dietary Cardiovascular Health and Expenditures Related to Acute Coronary Syndrome in the US between 2008-2018. International journal of environmental research and public health 20 (9) (2023)
Abraham M Enyeji, Noël Christopher Barengo, Boubakari Ibrahimou, Gilbert Ramirez, Alejandro Arrieta
Association between Non-Dietary Cardiovascular Health and Expenditures Related to Acute Coronary Syndrome in the US between 2008-2018. International journal of environmental research and public health 20 (9) (2023)
Abraham M Enyeji, Boubakari Ibrahimou, Noël C Barengo, Gilbert Ramirez, Alejandro Arrieta
Racial Disparities in Cardiovascular Health Among the Acute Coronary Syndrome Population. Population health management (2023)
Abraham M Enyeji, Noël Christopher Barengo, Boubakari Ibrahimou, Gilbert Ramirez, Alejandro Arrieta
Association between Non-Dietary Cardiovascular Health and Expenditures Related to Acute Coronary Syndrome in the US between 2008-2018. International journal of environmental research and public health 20 (9) (2023)